Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC01
- Pharmacological subgroupC01B
- Chemical subgroupC01BA
- Chemical substanceC01BA03Disopyramide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 12 registrations
- Rythmodan100 MG · Capsule · Cheplapharm Arzneimittel GMBH
- Norpace Cap 100MG100 MG · Capsule · Roberts Pharmaceutical Canada INC.
- Norpace Cap 150MG150 MG · Capsule · Roberts Pharmaceutical Canada INC.
- Norpace CR 150MG150 MG · Tablet (Extended-Release) · Shire Biochem INC
United States
FDA · 4 registrations
At a glance
- ATC code
- C01BA03
- ATC group
- Cardiovascular system
- Registers
- 7
- Registrations
- 23
- With their own page
- 10
- Companies
- 11
All medicines with Disopyramide
Human medicines from every register that match Disopyramide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
23 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Disopyramide Phosphate | United States | 100MG BASE, 150MG BASE | capsule | Marketed | Ivax Sub Teva Pharms |
| Disopyramide Phosphate | United States | 150MG BASE | capsule, extended release | Not marketed | Nesher Pharms |
| Norpace | United States | 100MG BASE, 150MG BASE | capsule | Marketed | Pfizer |
| Norpace CR | United States | 100MG BASE, 150MG BASE | capsule, extended release | Marketed | Pfizer |
| DICORYNAN 100 mg CAPSULAS DURAS | Spain | 100 mg | cápsula dura | Marketed | Cheplapharm Arzneimittel Gmbh |
| Ritmoforine Retard 250 mg, tabletten met gereguleerde afgifte | Netherlands | Tablet met gereguleerde afgifte | Authorised | CHEPLAPHARM Arzneimittel GmbH | |
| Rythmodan | Canada | 100 MG | Capsule | Not marketed | Cheplapharm Arzneimittel GMBH |
| Rythmodan - Cheplafarm | New Zealand | Cap 100 mg | Funded | ||
| Rythmodan (Cheplapharm) | New Zealand | Cap 100 mg | Funded | ||
| Rythmodan Neon | New Zealand | Cap 100 mg | Funded | ||
| Dicorantil F | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda | ||
| Norpace Ampoules 20MG/ML | Taiwan | 注射劑 | Cancelled | 凱盛國際股份有限公司 | |
| Norpace Cap 100MG | Canada | 100 MG | Capsule | Cancelled | Roberts Pharmaceutical Canada INC. |
| Norpace Cap 150MG | Canada | 150 MG | Capsule | Cancelled | Roberts Pharmaceutical Canada INC. |
| Norpace CR 150MG | Canada | 150 MG | Tablet (Extended-Release) | Cancelled | Shire Biochem INC |
| Rythmodan | Canada | 150 MG | Capsule | Cancelled | Sanofi-Aventis Canada INC |
| Rythmodan Cap 100MG | Canada | 100 MG | Capsule | Cancelled | Roussel Canada INC. |
| Rythmodan Cap 150MG | Canada | 150 MG | Capsule | Cancelled | Roussel Canada INC. |
| Rythmodan Capsules 100MG | Canada | 100 MG | Capsule | Cancelled | Hoechst Roussel Canada INC. |
| Rythmodan Capsules 150MG | Canada | 150 MG | Capsule | Cancelled | Hoechst Roussel Canada INC. |
| Rythmodan-LA | Canada | 250 MG | Tablet (Extended-Release) | Cancelled | Sanofi-Aventis Canada INC |
| Rythmodan-LA 250MG | Canada | 250 MG / SRT | Tablet (Extended-Release) | Cancelled | Hoechst Roussel Canada INC. |
| Rythmodan LA Tab 250MG | Canada | 250 MG | Tablet (Extended-Release) | Cancelled | Roussel Canada INC. |